Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer.
Albuquerque GAML, Guglielmetti GB, Barbosa JABA, Pontes J Jr, Fazoli AJC, Cordeiro MD, Coelho RF, Carvalho PA, Gallucci FP, Padovani GP, Park R, Cury J, Nonemacher H, Srougi M, Nahas WC.
Albuquerque GAML, et al. Among authors: cordeiro md.
Rev Assoc Med Bras (1992). 2017 Aug;63(8):704-710. doi: 10.1590/1806-9282.63.08.704.
Rev Assoc Med Bras (1992). 2017.
PMID: 28977109
Free article.